Literature DB >> 11921125

Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease.

Valeria Isella1, Paola Melzi, Marco Grimaldi, Simona Iurlaro, Roberto Piolti, Carlo Ferrarese, Lodovico Frattola, Ildebrando Appollonio.   

Abstract

Apathy is a salient feature of various neuropsychiatric disorders, from depression to Alzheimer's disease. We formally assess its prevalence in idiopathic Parkinson's disease (PD) together with its clinical, neuropsychological, and morphometric correlates. Thirty patients with PD and 25 normal controls were assessed using an extensive neuropsychological battery and Marin's Apathy Scale; parkinsonian patients also underwent MRI scan, followed by linear measurement of various frontotemporal structures. Approximately 45% of the PD sample showed apathy. For comparison analysis, given the unimodal distribution of the apathy scores, the PD sample was divided into three groups on the basis of the apathy tertiles. All three PD groups had worse cognitive and depression scores than controls, whereas they did not differ in terms of demographic, neurological, general cognitive, or affective features. By contrast, a significant positive association was found between apathy scores and performance on tests of executive function. As regards the morphometric data, we failed to find any specific measure of frontotemporal atrophy correlating with the presence or severity of apathy. Thus, apathy seems to be a frequent and important companion of PD, in many cases probably due to a primary motivational impairment, possibly related to a frontosubcortical dysfunction. Copyright 2002 Movement Disorder Society.

Entities:  

Mesh:

Year:  2002        PMID: 11921125     DOI: 10.1002/mds.10041

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  64 in total

1.  Apathy in Parkinson's disease.

Authors:  G C Pluck; R G Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Apathy and depression: separate factors in Parkinson's disease.

Authors:  Lindsey Kirsch-Darrow; Michael Marsiske; Michael S Okun; Russell Bauer; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2011-11       Impact factor: 2.892

Review 3.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

4.  Emotion and ocular responses in Parkinson's disease.

Authors:  J Dietz; M M Bradley; M S Okun; D Bowers
Journal:  Neuropsychologia       Date:  2011-08-04       Impact factor: 3.139

5.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

Review 6.  Managing Gait, Balance, and Posture in Parkinson's Disease.

Authors:  Bettina Debû; Clecio De Oliveira Godeiro; Jarbas Correa Lino; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-06       Impact factor: 5.081

Review 7.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

8.  The late positive potential, emotion and apathy in Parkinson's disease.

Authors:  J Dietz; M M Bradley; J Jones; M S Okun; W M Perlstein; D Bowers
Journal:  Neuropsychologia       Date:  2013-01-12       Impact factor: 3.139

9.  Toys and gadgets: construct validity of apathy in Parkinson's disease.

Authors:  Beata Ferencz; Bart Scholtissen; Milana Bogorodskaya; Michael S Okun; Dawn Bowers
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

10.  How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale?

Authors:  Lindsey Kirsch-Darrow; Laura B Zahodne; Chris Hass; Ania Mikos; Michael S Okun; Hubert H Fernandez; Dawn Bowers
Journal:  Mov Disord       Date:  2009-04-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.